Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Comerica Incorporated (CMA.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-02-2895.49103.00Neutral
2022-04-0190.0490.00Neutral
2022-04-2182.7393.00Neutral
2022-06-2476.52-No Rating
2023-03-1544.8368.00Buy
2023-04-1042.5658.00Buy
2023-04-2442.6455.00Buy
2023-07-1044.9551.00Buy
2023-07-2451.8356.00Buy
2023-09-2840.8149.00Buy
2023-10-2538.2945.00Buy
2024-01-0256.50-No Rating
2024-01-0856.8063.00Buy
2024-01-1952.6066.00Buy
2024-04-0452.7659.00Neutral
2024-04-1951.5655.00Neutral
2024-07-0850.0553.00Neutral
2024-07-2251.1150.00Neutral
2024-10-0258.1360.00Neutral
2024-12-1666.4764.00Sell
2025-01-2362.5361.00Sell
2025-04-0955.1059.00Neutral
2025-05-0754.6958.00Neutral

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 25% above the MRA for a Buy rating, and at -25% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.